ENvue Medical, Inc. (FEED)
| Market Cap | 230.90K -95.6% |
| Revenue (ttm) | 1.93M -17.7% |
| Net Income | -49.19M |
| EPS | -206.88 |
| Shares Out | 923.72K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 48,669 |
| Open | 0.2323 |
| Previous Close | 0.2221 |
| Day's Range | 0.2030 - 0.3000 |
| 52-Week Range | 0.1210 - 73.0800 |
| Beta | 1.45 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About ENvue Medical
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is desig... [Read more]
Financial Performance
In 2025, ENvue Medical's revenue was $2.55 million, a decrease of -0.20% compared to the previous year's $2.56 million. Losses were -$16.78 million, 352.8% more than in 2024.
Financial StatementsNews
ENvue Medical commences U.S production of UroShield
ENvue Medical (FEED) announced that UroShield production has commenced in the United States and that commercial shipments are underway to Peak Medical, the Company’s exclusive distributor in the Unite...
ENvue Medical CEO says ‘optimistic’ about opportunities ahead of company
ENvue Medical (FEED) issued a letter to shareholders from its CEO Doron Besser, MD, which read in part, “Our objective remains clear: to build a profitable ENvue Medical. I am…
ENvue Medical denied request for continued listing on Nasdaq
ENvue Medical (FEED) announced that it has received a decision from the Nasdaq Hearings Panel denying the company’s request for continued listing on The Nasdaq Capital Market. As a result,…
ENvue Medical Provides Nasdaq Listing Update
TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the “Company”), a medical technology company focused on innovative solutions for enteral feeding and the...
ENvue Medical resumes U.S. commercial shipments of PainShield
ENvue Medical (FEED) announced that it has resumed commercial shipments of PainShield, manufactured in the United States, and has begun fulfilling open orders from Ultra Pain Products, the company’s e...
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
TYLER, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical , Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding t...
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
TYLER, Texas, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company focused on real-time guided bedside feeding tube pla...
ENvue Medical Inc trading halted, news pending
19:50 EDT ENvue Medical (FEED) Inc trading halted, news pending
ENvue Medical announces 1-for-12 reverse stock split
ENvue Medical (FEED) announced that a reverse stock split of the company’s issued and outstanding common stock, par value $0.001 per share at a ratio of 1-for-12 is expected to…
ENvue Medical enters exclusive distribution agreement with Peak Medical
ENvue Medical (FEED) announced a new exclusive distribution agreement with Peak Medical to expand commercial distribution of ENvue’s UroShield device across the United Kingdom and Republic of Ireland....
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland Multi-year agreement with Peak Medical expands UroShield commercialization ...
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a...
ENvue Medical files $50M mixed securities shelf
16:21 EDT ENvue Medical (FEED) files $50M mixed securities shelf
ENvue Medical transitions NanoVibronix manufacturing operations to the U.S.
ENvue Medical (FEED) announced it has completed the transition of its NanoVibronix manufacturing operations from Israel to the United States, and consolidated its research and development operations i...
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical , Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transiti...
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
Additional Platform Deployment at Major Academic Medical Center Reflects Increasing Commercial Demand for Bedside Feeding Tube Navigation Additional Platform Deployment at Major Academic Medical Cente...
ENvue Medical chairman David Johnson to depart, Zeev Rotstein to succeed
ENvue Medical (FEED) announced that Zeev Rotstein, a current board member has been named chairman of the board, succeeding David Johnson, who is departing the board alongside fellow director Nino…
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing A...
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
ENvue Targeting Combined $10 Billion+ Enteral Feeding and Vascular Access Market Opportunity* ENvue Drive™ Demonstration Marks First Step Toward a New Generation of Intelligent Bedside Procedures and ...
Brazil Potash Awards Front End Engineering Design (FEED) Contract For Mine Shafts and Underground Development to WSP UK Ltd., with Redpath Deilmann Mining Inc. as Subconsultants, Completing Full-Project FEED Coverage at Autazes
MANAUS, Brazil, June 17, 2026 (GLOBE NEWSWIRE) -- Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a mineral exploration and development company advancing the Autazes potas...
Ohmium and Hynfra Sign Master Cooperation Agreement to Advance Large-Scale Green Hydrogen Projects in the Middle East and Africa
NEWARK, Calif. & WARSAW, Poland--(BUSINESS WIRE)-- #EnergyIndependence--Ohmium International Inc., a leading manufacturer of high-efficiency, modular Proton Exchange Membrane (PEM) electrolyzers, and ...
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers
ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
Second ENvue Navigation Platform Deployed Within the Same Health System Reflects the Clinical Confidence in Company's Real-Time Guided Feeding Tube Placement for Patients Second ENvue Navigation Platf...
ENvue Medical study highlights safety and cost-saving benefits of platform
ENvue Medical (FEED) announced the publication of an independent, peer-reviewed study in Critical Care Nurse highlighting the safety and cost-saving benefits of its ENvue Navigation Platform. The stud...
ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging